Rigel Pharmaceuticals, Inc. (RIGL) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.19 -3.34%
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Top Wealth Group expects net profit to double in fiscal 2026
- General Mills posts lower Q1 sales, reaffirms fiscal 2027 targets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
